Physician profile
Justin M Cox
NPI 1821144718
$291,499.49
in general payments reported to CMS, 2019-2025
42 companies · $4,916 in 2025
The $4,916 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71K · 2020: $48K · 2021: $97K · 2022: $39K · 2023: $7,897 · 2024: $23K · 2025: $4,916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $6,226 · Food and Beverage: $5,779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,762.50 |
| Travel and Lodging | $6,226.37 |
| Food and Beverage | $5,778.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $279,729.89 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Siemens Medical Solutions USA, INC. | $1,974.71 | 2022 | |
| Abbott Laboratories | $1,927.21 | 2019-2025 | Mitraclip, Aveir, Cardiomems |
| Medical Device Business Services, INC. | $1,176.83 | 2019 | |
| Shockwave Medical, INC | $1,067.66 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $960.29 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $835.01 | 2020-2025 | Lifevest |
| Inari Medical, INC. | $684.78 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $563.05 | 2022-2025 | Wholey, Abre, Hawkone |
| Medtronic Vascular, INC. | $319.84 | 2019-2020 | |
| Boston Scientific Corporation | $315.97 | 2019-2023 | Watchman Flx |
| Terumo Medical Corporation | $182.84 | 2021-2024 | Navicross |
| Penumbra, INC. | $155.58 | 2024 | Indigo System |
| Biosense Webster, INC. | $144.31 | 2023 | Carto 3 |
| Daiichi Sankyo INC. | $139.30 | 2023-2024 | Injectafer |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corindus INC. | $137.09 | 2019 | |
| Philips North America LLC | $115.92 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $112.30 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Cvrx, INC. | $97.87 | 2022-2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $70.69 | 2024 | Arcalyst |
| Stryker Corporation | $59.14 | 2025 | Clottriever Bold Catheter |
| Cleerly, INC. | $54.34 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.07 | 2022-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $52.17 | 2022-2025 | Verquvo, Winrevair |
| Astrazeneca Pharmaceuticals LP | $51.37 | 2021-2023 | Andexxa |
| Scpharmaceuticals INC. | $45.39 | 2023-2024 | |
| Lexicon Pharmaceuticals, INC. | $43.46 | 2024 | |
| Pfizer INC. | $43.36 | 2025 | |
| Cardiovascular Systems INC. | $43.31 | 2021 | |
| Novo Nordisk INC | $42.00 | 2023-2025 | Rybelsus, Ozempic |
| Bard Peripheral Vascular, INC. | $38.56 | 2025 | Lutonix Drug Coated Balloon |
| Alnylam Pharmaceuticals INC. | $37.72 | 2023-2024 | Amvuttra |
| Kiniksa Pharmaceuticals, LTD. | $36.43 | 2022-2023 | Arcalyst |
| Janssen Pharmaceuticals, INC | $29.74 | 2022 | |
| Angiodynamics, INC. | $28.99 | 2023 | Alphavac |
| Imperative Care, INC | $27.01 | 2024 | Prodigy Catheter |
| Reflow Medical INC | $20.43 | 2024 | |
| Novartis Pharmaceuticals Corporation | $19.24 | 2022 | |
| Chiesi USA, INC. | $16.38 | 2024 | Kengreal |
| Cathworks, INC. | $16.06 | 2021 | |
| Kestra Medical Technology Services, INC. | $15.94 | 2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $13.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.